Corbus Pharmaceuticals Holdings Inc (CRBP)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Yuval Cohen
Employees:
77
100 RIVER RIDGE DRIVE, NORWOOD, MA 02062
617-963-0103

Corbus Pharmaceuticals Holdings, Inc. engages in the development and commercialization of novel therapeutics to treat rare or uncommon chronic and serious inflammatory and fibrotic diseases with clear unmet medical needs. Its produc, JBT-101 is a novel synthetic oral endocannabinoid-mimetic drug that is intended to resolve chronic inflammation and halt fibrotic processes without causing immunosuppression. The company was founded in December 2013 and is headquartered in Norwood, MA.

Data derived from most recent annual or quarterly report
Market Cap 62.615 Million Shares Outstanding125.231 Million Avg 30-day Volume 1.123 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.76
Price to Revenue39.6651 Debt to Equity0.4139 EBITDA-108.255 Million
Price to Book Value3.4494 Operating Margin-3119.2039 Enterprise Value89.126 Million
Current Ratio2.887 EPS Growth-0.268 Quick Ratio2.678
1 Yr BETA 1.9655 52-week High/Low 4.0 / 0.5 Profit Margin-2826.0828
Operating Cash Flow Growth-118.0317 Altman Z-Score-5.3304 Free Cash Flow to Firm -89.036 Million
View SEC Filings from CRBP instead.

View recent insider trading info

Funds Holding CRBP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRBP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BRAKE RACHAEL LOUISE CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-12-06 2

CATLIN AVERY W

  • Director
116,400 2021-06-17 1

HOLMER ALAN F

  • Director
116,400 2021-06-17 1

JENKINS JOHN KENNETH

  • Director
116,400 2021-06-17 1

JACQUES RACHELLE SUZANNE

  • Director
116,400 2021-06-17 1

SALZMANN PETER

  • Director
116,400 2021-06-17 1

MORAN SEAN F. CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-02 1

WHITE BARBARA CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-02 1

COHEN YUVAL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-02-02 1

MILLIAN CRAIG STUART CHIEF COMMERCIAL OFFICER

  • Officer
0 2021-02-02 1

GOLUMBESKI GEORGE

  • Director
0 2020-07-06 0

HOCHMAN DAVID P

  • Director
0 2020-05-20 0

DISCORDIA ROBERT PAUL CHIEF OPERATING OFFICER

  • Officer
35,490 2020-03-17 0

PANAYIOTOPOULOS PARIS

  • Director
0 2019-05-22 0

TEPPER MARK PRESIDENT AND CSO

  • Officer
0 2019-01-18 0

GUPTA RENU

  • Director
0 2017-05-25 0

BURSTEIN SUMNER

  • FORMER 10% HOLDER
No longer subject to file 2015-11-16 0

KNOLL CAPITAL MANAGEMENT, LP

  • 10% Owner
2,750,000 2014-11-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BRAKE RACHAEL LOUISE - Officer CHIEF SCIENTIFIC OFFICER

2021-12-08 16:04:38 -0500 2021-12-06 A 500,000 a 500,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 22:15:03 UTC -0.5448 0.6148 3400000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 21:45:03 UTC -0.5448 0.6148 3400000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 21:15:04 UTC -0.5448 0.6148 3400000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 20:45:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 20:15:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 19:45:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 19:15:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 18:45:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 18:15:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 17:45:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 17:15:04 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 16:45:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 16:15:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 15:45:03 UTC -0.5448 0.6148 3300000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 15:15:03 UTC -0.5448 0.6148 3400000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 14:45:03 UTC -0.7489 0.8189 3400000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 14:15:03 UTC -0.7489 0.8189 3400000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 13:45:03 UTC -0.7489 0.8189 3400000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 13:15:03 UTC -0.7489 0.8189 2600000
CORBUS PHARMACEUTICALS HOLDI CRBP 2022-01-19 12:45:03 UTC -0.7489 0.8189 2500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund CRBP -23.0 shares, $-120.52 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund CRBP -31.0 shares, $-162.44 2020-03-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CRBP -300.0 shares, $-306.0 2021-09-30 N-PORT

Elevate your investments